Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-06-07 to 2023-06-29
Current total value of award: $773.7
Description: 4561201723!XOLAIR 150 MG/ML SYRINGEML